Treatment of TKI-sensitive NSCLC cells with TKI disrupted BECN1 phosphorylation and its interaction with Rubicon and BCL2, restored VPS34 activity, and triggered autophagy. This evidence concerns the gene PIK3C3 and non-small cell lung carcinoma.